Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

181 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The prevalence and clinical relevance of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ of the breast.
Pruneri G, Lazzeroni M, Bagnardi V, Tiburzio GB, Rotmensz N, DeCensi A, Guerrieri-Gonzaga A, Vingiani A, Curigliano G, Zurrida S, Bassi F, Salgado R, Van den Eynden G, Loi S, Denkert C, Bonanni B, Viale G. Pruneri G, et al. Among authors: zurrida s. Ann Oncol. 2017 Feb 1;28(2):321-328. doi: 10.1093/annonc/mdw623. Ann Oncol. 2017. PMID: 28426105 Free article.
Ductal carcinoma in situ and intraoperative partial breast irradiation: Who are the best candidates? Long-term outcome of a single institution series.
Leonardi MC, Corrao G, Frassoni S, Vingiani A, Dicuonzo S, Lazzeroni M, Fodor C, Morra A, Gerardi MA, Rojas DP, Dell'Acqua V, Marvaso G, Bassi FD, Galimberti VE, Veronesi P, Miglietta E, Cattani F, Zurrida S, Bagnardi V, Viale G, Orecchia R, Jereczek-Fossa BA. Leonardi MC, et al. Among authors: zurrida s. Radiother Oncol. 2019 Apr;133:68-76. doi: 10.1016/j.radonc.2018.12.030. Epub 2019 Jan 17. Radiother Oncol. 2019. PMID: 30935584
Breast cancer subtypes and outcome after local and regional relapse.
Montagna E, Bagnardi V, Rotmensz N, Viale G, Renne G, Cancello G, Balduzzi A, Scarano E, Veronesi P, Luini A, Zurrida S, Monti S, Mastropasqua MG, Bottiglieri L, Goldhirsch A, Colleoni M. Montagna E, et al. Among authors: zurrida s. Ann Oncol. 2012 Feb;23(2):324-31. doi: 10.1093/annonc/mdr129. Epub 2011 Apr 27. Ann Oncol. 2012. PMID: 21525402 Free article.
Male breast cancer: a special therapeutic problem. Anything new? (Review).
Gennari R, Curigliano G, Jereczek-Fossa BA, Zurrida S, Renne G, Intra M, Galimberti V, Luini A, Orecchia R, Viale G, Goldhrisch A, Veronesi U. Gennari R, et al. Among authors: zurrida s. Int J Oncol. 2004 Mar;24(3):663-70. Int J Oncol. 2004. PMID: 14767551 Review.
Breast cancer classification: time for a change.
Veronesi U, Zurrida S, Goldhirsch A, Rotmensz N, Viale G. Veronesi U, et al. Among authors: zurrida s. J Clin Oncol. 2009 May 20;27(15):2427-8. doi: 10.1200/JCO.2008.21.2647. Epub 2009 Apr 20. J Clin Oncol. 2009. PMID: 19380438 No abstract available.
Pathological complete response after preoperative systemic therapy and outcome: relevance of clinical and biologic baseline features.
Montagna E, Bagnardi V, Rotmensz N, Viale G, Pruneri G, Veronesi P, Cancello G, Balduzzi A, Dellapasqua S, Cardillo A, Luini A, Zurrida S, Gentilini O, Mastropasqua MG, Bottiglieri L, Iorfida M, Goldhirsch A, Colleoni M. Montagna E, et al. Among authors: zurrida s. Breast Cancer Res Treat. 2010 Dec;124(3):689-99. doi: 10.1007/s10549-010-1027-4. Epub 2010 Jul 13. Breast Cancer Res Treat. 2010. PMID: 20625816
Nonpalpable breast carcinomas: long-term evaluation of 1,258 cases.
Veronesi U, Luini A, Botteri E, Zurrida S, Monti S, Galimberti V, Cassano E, Latronico A, Pizzamiglio M, Viale G, Vezzoli D, Rotmensz N, Musmeci S, Bassi F, Burgoa L, Maisonneuve P, Paganelli G, Veronesi P. Veronesi U, et al. Among authors: zurrida s. Oncologist. 2010;15(12):1248-52. doi: 10.1634/theoncologist.2010-0123. Epub 2010 Dec 8. Oncologist. 2010. PMID: 21147866 Free PMC article.
181 results